Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
Ossama Mansour, Chief Executive Officer of a Semoha University Campus, Faculty of Medicine at Alexandria University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”We are proud to highlight the publication of the first comprehensive, resource-stratified guidelines for acute ischemic stroke management in the Middle East and North Africa an initiative that represents years of collaborative work by 45 multidisciplinary experts from 22 countries, published in ‘Neurological Research‘ (2026).
Why does this matter?
The MENA region bears a disproportionate stroke burden. Approximately 75% of stroke-related deaths worldwide occur in low- and middle-income countries.
In our region, strokes strike nearly a decade earlier than in Western populations (mean age 58–62 vs. 68–72 years), against a backdrop of high diabetes prevalence (8–20%), hypertension (26–38%), and smoking rates exceeding 50% in men.
Yet until now, clinical guidance has been directly transplanted from Western or East Asian evidence — often without accounting for our geography, culture, healthcare infrastructure, conflict realities, or economic constraints.
What these guidelines deliver:
Using the MENA-SINO systematic seven-step adaptation framework and adhering to AGREE II standards, the expert panel synthesized evidence from AHA/ASA, ESO, NICE, and Chinese Stroke Association guidelines alongside 186 regional publications.
Through three rounds of modified Delphi consensus achieving >85% agreement, the guidelines introduce:
- A tiered (3-level) hub-and-spoke stroke care system adapted to MENA realities
- The ‘Drip and Ship’ model with MENA-specific ’30-Minute Rule’ for urban traffic
- Tenecteplase as the preferred thrombolytic for resource-limited settings (single bolus advantage)
- Clear EVT guidance for large core infarcts, basilar artery occlusion, and medium vessel occlusions
- Culturally sensitive decision-making frameworks including family-centered consent and Ramadan-specific protocols
- Conflict zone and refugee population management strategies
- Secondary prevention tailored to regional risk factor patterns, including ICAD-specific DAPT protocols
- Cost-effectiveness analyses guiding resource prioritization
The numbers that drive urgency:
- Door-to-needle time regional benchmark: currently 145 minutes target: <60 minutes
- IVT rate in eligible patients: currently only 12% target: >60% for Tier 2 centers
- Stroke mortality in conflict zones: up to 65%
- Mechanical thrombectomy available in fewer than 30% of stroke-receiving hospitals
These guidelines are a living document.
They call upon Ministries of Health, international organizations, research institutions, and every neurologist, emergency physician, and nurse in the region to act because time is brain, and our patients deserve evidence that speaks their language.
Overflowing with pride and a deep sense of gratitude, I feel incredibly fortunate to stand shoulder to shoulder with this powerhouse constellation of regional experts a brilliant league of minds united by one bold mission: to revolutionize stroke care across our region.”
Title: MENA-adapted guidelines for acute ischemic stroke management: a regional approach to global evidence
Authors: Ossama Yassin, Mohamad Ezzeldin, May Nour, Ameer Hassan, Syed Zaidi, Mouhammad Jumaa, Farid Aladham, Ibrahim Alnaami, Hosam Al-Jehani, Abdulrahman Alshamy, Faisal Alghamdi, Atilla Ozdemir, Tamer Hassan, Hany Eldeen, Hany Hamadani, M. Hussain, Ehsan Sharifipour, Erdem Gurkas, Mohamed Habib, Nadia Hammami, Hosam Salah, Farouk Hassan, Syed Hussain, Yahia Imam, Seby John, Adnan Qureshi, Amina El Khamlichi, Amr Mahmoud, Ahmed Ossama, Mostafa Mahmoud, Ehab Mohamed, Nada Nasr, Umair Rashid, Salma Said, Abdulmonem Saied, Maher Saqqur, Khalid Sobh, Mohammed Wasay, Mohammed Ghorbani, Jeyaraj Pandian, Adnan Siddiqui, Ashfaq Shuaib
Read the Full Article on Neurological Research

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges
-
Apr 15, 2026, 14:29Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins
-
Apr 15, 2026, 14:25Prince Alfred Singh։ Understanding Antithrombin III Deficiency as a High-Risk Thrombophilia